fbpx Australia: MMJ PhytoTech Moves a Step Closer to Importing Medicinal Cannabis | Marijuana Business News | Cannabis Industry & Legalization | 420 Intel

Australia: MMJ PhytoTech Moves a Step Closer to Importing Medicinal Cannabis

MMJ's Australian distribution partner has received import licence.

MMJ PhytoTech’s (ASX:MMJ) Australian distribution partner, HL Pharma, has received approval for a medicinal cannabis importation licence from the Department of Health, Australia.

This is an important development for MMJ as it enables the direct supply to Australian pharmacies through its strategic partnership with Melbourne-based HL Pharma.

HL Pharma will use its extensive distribution network to facilitate the sale of MMJ’s Swiss subsidiary Satipharm AG’s cannabidiol (CBD) capsules to approved customers.

Satipharm’s Gelpell CBD capsules are produced in Switzerland and have successfully undergone a phase 1 clinical trial for safety.

Importantly, Satipharm’s CBD capsules are set to become one of the first medicinal cannabis products available to approved customers in Australia.

Satipharm has the necessary inventory to immediately commence the importation of its CBD capsules into Australia.

Incidentally, the Canadian Federal Government has confirmed it will...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: